Newsletter | January 9, 2025

01.09.25 -- FDA Issues New Guidance: Nonclinical Safety Assessment Of Oligonucleotide-Based Therapeutics

SPONSOR

The peptide market is booming, driving manufacturers to enhance processes and capacity. What key changes are shaping peptide manufacturing? How can continuous manufacturing boost efficiency and meet demand? Don’t miss our inaugural Pharmaceutical Online Live digital event on January 22nd. Registration is free thanks to the support of Federal Equipment Company.

INDUSTRY INSIGHTS

X-Ray Detection Guide: How To Maximize Performance, ROI, And OEE

How do you choose the right X-ray inspection system? This guide outlines everything you need to know to select a system to meet your detection goals in a way that maximizes ROI and OEE.

Is Lipinski's Rule Of Five Still Relevant In Drug Development?

Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.

The Business Value Of Connectivity For Product Inspection Equipment

Realize the value of connectivity, and more specifically, the value of the information provided by checkweighing, metal detection, vision inspection, and X-ray inspection.

Leveraging ISA-95 In A Pharma 4.0 World

Explore core elements of the ISA-95 specification and how life sciences manufacturers can apply them within an integration solution designed for industrial data modeling, delivery, and governance.

Accelerated Development Of OSD Formulation For IND Submission

This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval.

Process Re-Design For Sustainability In Small Molecule Manufacturing

Review the optimization of the manufacturing process of a pharmaceutical intermediate, and discover how yield can be improved substantially via suitable reaction engineering.

Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability

A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

Ensuring Quality And Safety Through Process Optimization, Characterization

Process replication at a small scale, verification runs, and satellite runs conducted in parallel to manufacturing are valuable risk mitigation tools that maximize efficiency and product quality.

Product D-Value Study - Part 2, Heat-Sensitive And Atypical Aqueous Liquids

How can your organization use this critical tool when developing your sterilization process for heat-sensitive products and low F0 cycles?

Mobile Gowning Cleanroom, Built To Meet ISO 7 Requirements

Learn how Germfree designed and installed a mobile cGMP cleanroom on a 53′ tractor-trailer chassis to provide a flexible and efficient cleanroom solution tailored to the company’s needs.

Adapting Single-Use Chromatography To Manufacturing Scale

Explore strategies for accommodating the ever-increasing upstream titers and volumes to prevent downstream purification from becoming a bottleneck.

FEATURED EDITORIAL

FDA Issues New Guidance On Nonclinical Safety Of Oligonucleotide-Based Therapeutics

FDA's CDER recently issued a draft guidance: Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics. This article provides a summary and analysis. The public comment period ends January 14, 2025.

SOLUTIONS

Capacity Update October 2024: Fill/Finish

Traceability And Compliance: The Keys To A Safe And Efficient Lab

Capacity Update October 2024: Fill/Finish

Proper Wiping Technique In Critical Environments

Capacity Update October 2024: Fill/Finish

Connect With Pharmaceutical Online: